KRT40: A Potential Drug Target for Neurological Disorders (G125115)

Target Name: KRT40

NCBI ID: G125115

KRT40

KRT40: A Potential Drug Target for Neurological Disorders

KRT40 (KRT40 variant 1) is a protein that is expressed in the brain and is known for its role in the regulation of cell survival and differentiation. The KRT40 protein has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

KRT40 is a member of the KRT gene family, which is known for the regulation of kallikrein genes, which are involved in the production of inflammatory cytokines. The kallikrein genes have been implicated in the development of various inflammatory diseases, including autoimmune diseases, cancer, and neurodegenerative diseases.

KRT40 is expressed in the brain and is involved in the regulation of various cellular processes, including cell survival, apoptosis (programmed cell death), and cell proliferation. It has been shown to play a role in the regulation of neurogenesis, which is the process by which new neurons are produced in the brain.

KRT40 has been shown to interact with various protein targets, including the neurotransmitter receptor N-methyl-D-aspartate (NMDA). NMDA is involved in the regulation of neural function and is known to play a role in the development of various neurological disorders, including Alzheimer's disease and depression.

In addition to its role in neurogenesis, KRT40 has also been shown to be involved in the regulation of neurotransmitter release and uptake. It has been shown to interact with the neurotransmitter acetylcholine (ACh), which is involved in the regulation of memory and cognitive function.

KRT40 has also been shown to play a role in the regulation of inflammation and immune response. It has been shown to interact with the immune system protein PD-L1, which is involved in the regulation of immune cell function.

KRT40 has been shown to be involved in the development of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. Studies have shown that individuals with certain genetic variations in the KRT40 gene are at increased risk for the development of these disorders.

In conclusion, KRT40 is a protein that has been identified as a potential drug target and biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand the role of KRT40 in these disorders and to develop effective treatments.

Protein Name: Keratin 40

Functions: May play a role in late hair differentiation

The "KRT40 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT40 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets